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Vertebrate gonads are the sites of synthesis and binding of many peptides that were initially 
classified as neuropeptides. These gonadal neuropeptide systems are neither well understood 
in isolation, nor in their interactions with other neuropeptide systems. Further, our knowledge of 
the control of these gonadal neuropeptides by peripheral hormones that bind to the gonads, and 
which themselves are under regulation by true neuropeptide systems from the hypothalamus, 
is relatively meager. This review discusses the existence of a variety of neuropeptides and their 
receptors which have been discovered in vertebrate gonads, and the possible way in which such 
systems could have evolved. We then focus on two key neuropeptides for regulation of the 
hypothalamo-pituitary-gonadal axis: gonadotropin-releasing hormone (GnRH) and gonadotropin-
inhibitory hormone (GnIH). Comparative studies have provided us with a degree of understanding 
as to how a gonadal GnRH system might have evolved, and they have been responsible for the 
discovery of GnIH and its gonadal counterpart. We attempt to highlight what is known about these 
two key gonadal neuropeptides, how their actions differ from their hypothalamic counterparts, 
and how we might learn from comparative studies of them and other gonadal neuropeptides 
in terms of pharmacology, reproductive physiology and evolutionary biology.
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gonadotropin-releasing hormone (GnRH), Jones and Hsueh, 1981; 
Bahk et al., 1995; Pati and Habibi, 1998; gonadotropin- inhibitory 
hormone (GnIH), Hinuma et al., 2000; Bentley et al., 2008; 
kisspeptin, Castellano et al., 2006). The presence of neuropeptide 
receptors in the gonads: GnRH-R in mammals (Jones et al., 1980; 
Whitelaw et al., 1995; Schirman-Hildesheim et al., 2005)and fish, 
(von Schalburg et al., 1999; Bogerd et al., 2002); galanin receptor 
in mammals (Romanelli et al., 1998); vasoactive intestinal peptide 
receptor (VIP-R) in birds and mammals (Johnson and Tilly, 1988; 
Kawashima, 1995; El-Gehani et al., 1998; Bajo et al., 2000; Vaccari 
et al., 2006); NPY-R in mammals (Kopp et al., 1997); CRF-R in 
mammals (Heinrich et al., 1998; Waser et al., 2006), urocortin 
receptor in mammals (Florio et al., 2004) and kisspeptin receptor 
(GPR54) in mammals (Shahed and Young, 2009), supports this 
function. See Table 1 for further clarification.
In the same way that synthesis and actions of steroids in the 
brain or other, non-gonadal tissues are often overlooked (Schmidt 
et al., 2008), so are the synthesis and actions of gonadal neu-
ropeptides. It is likely that the synthesis and actions of these 
hormones are often not taken into consideration in endocrine 
studies because they fall outside the classic endocrine axes (for 
example, the hypothalamo-pituitary-gonadal [HPG] axis). It is 
also sometimes harder to manipulate these systems in isolation 
within the gonads or brain than as intact components of the clas-
sic axes. Generally, neural or gonadal tissue needs to be cultured 
ex vivo in order to gain some understanding of the hormone of 
interest that they produce, which of course limits interpretation. 
Furthermore, although it is somewhat logical to assume that the 
brain is able to interpret environmental and physiological cues 
and regulate its own steroid production, it is harder to  understand 
IntroductIon
“What’s in a name? That which we call a rose
By any other name would smell as sweet.”
Romeo and Juliet (Act 2, scene 2)
Neuropeptides appear to be appropriately named: they are 
peptides synthesized by neurons in the central nervous system. 
However, what matters is what they do, not what they are called, 
and we shall see in this review that neither the synthesis nor actions 
of neuropeptides are limited to the brain. This article focuses on 
“neuropeptides” in the gonads of vertebrates, with special empha-
sis on what we can learn from pharmacological experiments on 
gonadal tissue and then apply to our understanding of an animal’s 
ecology in the wild.
Investigating the presence of neuropeptides in the gonads of a 
diverse array of species will provide us with information as to the 
possible evolutionary origins, adaptations, interactions and func-
tions of what we are choosing to term “gonadal neuropeptide” sys-
tems. The conservation of localized gonadal regulation by gonadal 
neuropeptides across vertebrates has important implications for 
understanding the evolution, reproductive physiology and ecology 
of animals, along with the study and practice of reproductive health 
and medicine, both clinical and veterinary.
neuropeptIdes In the gonads
Many neuronally produced hormones with important endocrine, 
behavioral, sensory and autonomic roles in the vertebrate brain are 
also expressed by and may act directly within the gonads (Table 1; 
neuropeptide Y (NPY), Achi et al., 1995; bradykinin, Singh et al., 
2007; corticotropin releasing factor (CRF), Huang et al., 1995; 
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very close to the gonads and acted directly on the gonads (Powell 
et al., 1996). More evidence for this scenario comes from bivalve 
mollusks (Pazos and Mathieu, 1999). The vertebrate gonads may 
thus have retained the capability of at least responding to neu-
ropeptides directly, but this does not enlighten us as to how the 
gonads have retained (or acquired) the capability of synthesiz-
ing neuropeptides such as GnRH. Additionally, all isoforms of 
GnRH are bioactive (affect DNA synthesis) in the molluskan 
gonad. The protochordate Ciona intestinalis, synthesizes two 
isoforms of GnRH, mammalian GnRH (mGnRH) and chicken 
GnRH-II (cGnRH-II), in its gonads (Di Fiore et al., 2000). Ciona 
gonads cultured in vitro with both isoforms show an increase in 
sex steroid synthesis and release. The gonads of vertebrates may 
thus have retained the capability of producing and responding to 
neuropeptides directly. As well, in higher vertebrates, local con-
trol of the gonads may have been retained for rapid, transient 
how the gonads might respond to similar cues outside of the 
framework of the classic HPG axis. How, for example, does a 
gonad regulate its own GnRH production? Can a gonad respond 
to changes in day length, or social stimuli, or stress? How are 
these stimuli perceived?
Another consideration is that it might seem hard to understand 
why a gonadal neuropeptide system exists and how it evolved? The 
primary functions of gonads are to synthesize gonadal steroids 
and produce gametes, both of which appear to be exquisitely regu-
lated and accomplished by the H-P components of the HPG axis. 
An additional, internal regulatory system in the gonad appears at 
first glance to be superfluous. It is possible that in early vertebrates, 
neural tissue containing neuropeptides and gonadal tissue were 
not as disparate as they are in modern vertebrates. It is thought 
that before the evolution of the vertebrate pituitary gland, GnRH 
neurons might have released GnRH directly into the bloodstream 
Table 1 | Presence of neuropeptides in the gonads of vertebrates. GnRH isoforms appear to be highly conserved across vertebrates, but there are large 
gaps in our knowledge of the evolution of other gonadal neuropeptides.
Neuropeptide Protochordates Agnathans Fish Amphibians Reptiles Birds Mammals
lGnRH-I/
lGnRH-III
Gazourian 
et al. (1997)
sGnRH Madigou et al. 
(2002)
cGnRH-II Di Fiore et al. 
(2000)
Andreyu-Vieyra 
(2000)
Sun et al. 
(2001)
Kang et al.
(2001)
mGnRH/
GnRH-I
Di Fiore et al. 
(2000)
Hsueh et al. 
(1981)
Minucci et al. 
(1986)
Hertelendy 
et al. (1982)
Clayton et al. 
(1979)
GnIH Bentley et al. 
(2008)
Zhao et al. 
(2010)
CRH Garcia-Reyero 
(2009)
Huang et al.
(1995)
TRH Geris et al. 
(2000)
Pekary et al. 
(1980)
GHRH McRory et al. 
(1995)
Campbell and 
Scanes (1992)
VIP El-Gehani et al. 
(1998)
Oxytocin Kawada et al. 
(2008)
Nicholson 
et al. (1984)
PACAP McRory et al. 
(1995)
Arimura et al. 
(1991)
POMC Masini et al. 
(1997)
Shen et al. 
(2003)
Endo and Park 
(2004)
Takeuchi 
et al. (1999)
Pintar et al. 
(1984)
ANP Akiho et al. 
(1995)
NPY MacDonald and 
Volkoff (2009)
Achi et al. 
(1995)
Terado (2006)
Secretin Ohta et al. 
(1992)
Substance P Schulze et al. 
(1987)
GnRH, Gonadotropin-releasing hormone; lGnRH, isoforms from lamprey; sGnRH, salmon; cGnRH-II, chicken; mGnRH/GnRH-I, mammals; GnIH, Gonadotropin 
inhibiting hormone; CRH, Corticotropin releasing hormone, TRH, Thyrotropin releasing hormone; GHRH, Growth hormone releasing hormone; VIP, Vasoactive 
intestinal peptide; PACAP, Pituitary adenylate cyclase activating peptide; POMC, Pro-opiomelanocortin; ANP, Atrial natriuretic peptide; NPY, Neuropeptide Y.
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In addition to mammals, protochordates, fish, amphibians, 
reptiles and birds also express isoforms of GnRH and GnRH-R 
in their testes and ovaries (von Schalburg et al., 1999; Di Fiore 
et al., 2000; Sun et al., 2001; Canosa et al., 2002; Ikemoto and Park, 
2007). See Table 1.
effects of gonadal gnrh are Isoform-, specIes- and 
sex-dependent In non-mammalIan vertebrates
The gonadal GnRH system has a diversity of functions in non-
mammalian vertebrates. As mentioned earlier, the gonads of the 
protochordate Ciona intestinalis, synthesize both mGnRH and 
cGnRH-II (Di Fiore et al., 2000). Ciona gonads cultured in vitro 
with these isoforms show an increase in testosterone, progesterone 
and estradiol synthesis and release. A lamprey isoform of GnRH 
(lGnRH-III) significantly stimulates basal estradiol production and 
ovulation in the ovary and significantly increases estradiol and pro-
gesterone production in the testes of lampreys in vitro (Gazourian 
et al., 1997). In a later study, two isoforms of lGnRH, lGnRH-I and 
–III, independently stimulated estradiol production by lamprey 
testis in vitro, with lGnRH-III being the more potent of the two 
GnRH isoforms used. In contrast to their earlier study, the authors 
conclude there is no direct effect of either form of lGnRH on the 
ovary in this study, although the authors do state that “lamprey 
GnRH-III at 1000 ng/ml directly stimulated the ovaries incubated 
at 14°C (P < 0.05) (data not shown)” (Gazourian et al., 2000). Taken 
together, it seems that the lGnRHs are capable of acting directly on 
male and female lamprey gonads to elicit steroid production.
The differential expression of GnRH isoforms and their cognate 
receptors in rainbow trout gonads indicates a role for these peptides 
in paracrine/autocrine regulation of gonadal function in this spe-
cies. In the rainbow trout (Oncorhynchus mykiss), salmon GnRH 
(sGnRH) mRNA from whole testes increases as the spermatogenic 
cycle proceeds while chicken GnRH (cGnRH-II) mRNA decreases 
(Madigou et al., 2002). GnRH-R mRNA 1, which putatively codes 
for the receptor that binds sGnRH, also increases in whole testes as 
spermatogenesis progresses (Madigou et al., 2002). Stage-specific 
expression indicates sGnRH may be associated with spermatogenic 
development while cGnRH-II may hinder it. In whole ovaries, 
GnRH-R type 1 mRNA was undetectable in the same study, but 
sGnRH, cGnRH-II and GnRH-R type 2 mRNA were expressed from 
the beginning of vitellogenesis to post-ovulation (Madigou et al., 
2002). Although the manner of this regulation remains unclear, 
when combined with functional evidence from goldfish- sGnRH 
and cGnRH-II inhibit gonadotropin-stimulated oocyte meiosis and 
follicular testosterone production (Pati and Habibi, 2000)- sGnRH 
and cGnRH-II are most probably involved in regulation of follicular 
hierarchy and/or maturation via inhibitory actions.
In toads (Bufo arenarum), mammalian GnRH (mGnRH or 
GnRH-I) inhibits basal and human chorionic gonadotropin 
(hCG)-stimulated testosterone release in the testes by decreas-
ing the activity of cytochrome P450c17 (steroid 17 alpha-
hydroxylase/17,20 lyase) (Hsueh et al., 1981). In leopard frogs, 
Rana pipiens, and bullfrogs, R. catesbeiana, no action of 1000 ng/
ml GnRH was observed on testosterone or progesterone secre-
tion from mature follicles coincidently incubated with pituitary 
homogenate or with bullfrog LH (Hubbard and Licht, 1985). 
Which isoform of GnRH used here is not clear from this study, 
responsiveness to environmental and physiological stimuli. It is 
less clear what the regulatory mechanisms governing the synthesis 
of these gonadal neuropeptides might be.
neuropeptIdes of the hpg axIs In the gonads
Vertebrate gonadal tissues typically synthesize and contain recep-
tors for several hormones that are classified as neuropeptides. For 
example, GnRH, a key hormone for vertebrate reproduction, and its 
receptor are present in the gonads of fish, amphibians, birds, reptile 
and mammals (Hsueh and Jones, 1981; Oikawa et al., 1990; Bahk 
et al., 1995; Grober et al., 1995; Di Matteo et al., 1996; Dong et al., 
1996; Lin and Peter, 1996; Pati and Habibi, 1998; von Schalburg 
et al., 1999; Sun et al., 2001; Bogerd et al., 2002; Ikemoto and Park, 
2007). Gonadal GnRH most likely plays an autocrine/paracrine 
function in the regulation of gonadal development and activity. 
For example, its action includes testicular steroidogenesis in rats 
and frogs (Hsueh et al., 1983; D’Antonio et al., 1992), sperma-
togenesis in fish (Andreu-Vieyra and Habibi, 2001; Andreu-Vieyra 
et al., 2005) and oocyte meiosis and follicular steroidogenesis in fish 
(Pati and Habibi, 2000). There is also variation in the expression 
of GnRH and GnRH-R across the estrus cycle and in a circadian 
manner in rats (Schirman-Hildesheim et al., 2005, 2006), although 
specific function has yet to be assigned to this variation.
Along with GnRH, this article will place emphasis on another 
neuropeptide involved in the HPG axis: GnIH. This neuropeptide 
was discovered 10 years ago in Japanese quail (Tsutsui et al., 2000), 
when it was isolated and found to inhibit pituitary luteinizing hor-
mone (LH) release. It is now known that GnIH is a regulator of 
pituitary gonadotropin synthesis and release in birds and mammals 
(Tsutsui et al., 2000, 2007; Ciccone et al., 2004; Osugi et al., 2004; 
Bentley et al., 2006a; Kriegsfeld et al., 2006; Tsutsui and Ukena, 
2006; Ubuka et al., 2006; Johnson et al., 2007; Clarke et al., 2009; 
Sari et al., 2009).
gnrh In the gonads
Gonadotropin-releasing hormone was initially characterized as a 
hypothalamic neuroendocrine regulator of LH and follicle stim-
ulating hormone (FSH) synthesis and release from the anterior 
pituitary gland (Ling et al., 1973; Schally et al., 1971). Evidence 
now exists that GnRH is also produced in, binds to and exerts a 
local action on the gonads. Several isoforms of GnRH (identified 
by both species letters and isoform numbers) and GnRH receptor 
are present in the gonads of vertebrates and will be discussed below. 
Many species possess multiple isoforms, including isoforms named 
as a result of their initial discovery in other species.
GnRH-I and GnRH type 1 receptor (GnRH-I R) are expressed 
in the mammalian gonads. This isoform is also known as mam-
malian GnRH (mGnRH). GnRH-I mRNA and GnRH-I R mRNA 
have been identified in granulosa and luteal cells of adult female 
rats (Oikawa et al., 1990; Whitelaw et al., 1995) and humans (Peng 
et al., 1994). In males, GnRH-I mRNA is present in Sertoli cells and 
germ cells of adult rats and humans, while the interstitial layer of 
the testis expresses GnRH-I R mRNA (Bahk et al., 1995). Gonadal 
GnRH is also expressed in fetal rats (Botté et al., 1998). In addition 
to GnRH-I, primate testes and ovaries express a second GnRH 
isoform, first characterized in chicken (cGnRH-II) and its receptor, 
GnRH type 2 receptor.
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effects of gonadal gnrh on steroId bIosynthesIs In the 
mammalIan ovary
In female rats, GnRH-I is highly expressed and functional in the 
corpus luteum and in granulosa cells. Pharmacological levels of 
GnRH-I (0.5 uM) decrease basal luteal progesterone synthesis, 
but hCG (at concentrations greater than 10−13 M) is able to res-
cue this effect (Clayton et al., 1979). Cultured rat granulosa cells 
experience a significant reduction in estradiol (E2) and proges-
terone production stimulated by FSH in the presence of GnRH-I. 
No change in total mass occurs, apparently precluding an effect 
of GnRH in cell death (Hsueh and Erickson, 1979), although 
GnRH agonists have since been implicated in the promotion of 
ovarian apoptosis (Takekida et al., 2003). A later experiment by 
Hsueh et al. (1980) showed that GnRH reduces E2 production by 
preventing the FSH-induced 12-fold increase in LH/hCG recep-
tor expression in granulosa cells. If GnRH indirectly reduces E2 
production via reduced LH/hCG receptors in the ovary, ovar-
ian androgen production should be directly reduced as well. 
Prepubertal female rat ovaries cultured with hCG, LH and leu-
prolide acetate, a GnRH agonist, show a concomitant decrease 
in both androsterone and P450(C17) enzyme activity relative to 
ovaries treated with hCG/LH alone (Irusta et al., 2007). As we have 
already mentioned, GnRH-I inhibits P450(C17) in toad (Bufo 
arenarum) testes, resulting in decreased testosterone secretion 
(Canosa, 2002). Thus this property may be evolutionarily con-
served. GnRH-I also appears to inhibit FSH-stimulated aromatase 
activity in addition to P450(C17) inhibition in rat granulosa, but 
not Sertoli cells (Gore-Langton et al., 1981). The sex difference 
is likely due to the lack of GnRH-I R on male rat Sertoli cells. 
Again, there appears to be a sex and/or tissue difference, where 
GnRH is acting upstream of progesterone synthesis in the female 
corpus luteum but downstream of progesterone synthesis in male 
Leydig cells. Interestingly, the inhibitory effect of GnRH agonist 
on 17β-estradiol and progesterone secretion occurred in granu-
losa cells from large but not from small and medium follicles. The 
stimulatory effect of GnRH agonist on apoptosis was, however, 
uniform regardless of the stages of follicular growth (Takekida 
et al., 2003). Thus GnRH-I potentially exerts diverse actions on 
granulosa cells over the course of follicular growth. One is to 
downregulate granulosa cell proliferation in immature follicles 
as well as steroidogenesis in mature follicles, and the other is to 
upregulate apoptosis of granulosa cells, regardless of the stage 
of follicular growth.
Functionally, local GnRH action on estrogen synthesis may not 
be needed to regulate estrogen production in males, as estrogen 
has a much larger contribution to gametogenesis in females and 
would require tighter control in that sex. GnRH-I inhibits both 
androgen and consequently estrogen production in rat ovaries. In 
rat testes, GnRH-I primarily inhibits testosterone production. In 
both sexes, local GnRH modulates and primarily limits the major 
steroid supporting gamete maturation.
gonadal gnrh In prImates
Humans and other primates express both mammalian GnRH 
(mGnRH/GnRH-I) and cGnRH-II and their cognate receptors 
(GnRH type 1 receptor/GnRH-I R and GnRH type 2 receptor/
but we assume that it was mGnRH- this is important as different 
isoforms appear to have different effects. This may be one reason 
why some studies show inhibition while others show stimulation. 
In another, contrasting study on ovaries of frog (Rana esculenta), 
lizard (Podarcis sicula sicula) and fish (Torpedo ocellata and Gobius 
paganellus) indicated that the action of GnRH in the gonads 
may be species-dependent. In frogs, a GnRH agonist (GnRHa, 
HOE766) inhibited LH-induced progesterone release (Minucci 
et al., 1986) whereas in lizards, GnRHa stimulated progesterone 
production in preovulatory follicles. In both fish species studied 
no effects of GnRHa or ovine LH were seen. However, in a later 
study on goldfish (Carassius auratus), sGnRH and cGnRH-II 
increased testicular apoptosis, indicating a paracrine role for 
GnRH in the control of apoptosis. This effect of sGnRH and 
cGnRH-II on apoptosis was also observed in goldfish ovaries 
(Andreu-Vieyra and Habibi, 2000).
In cockerels (Gallus domesticus), both cGnRH-II and cGnRH-R 
are expressed in the testes in addition to the brain and although 
its regulatory role has not been tested, estrogen treatment appears 
to reduce the concentration of cGnRH-II in the testes (Sun et al., 
2001). GnRH can directly alter steroid biosynthesis in chicken 
ovaries: LH- stimulated progesterone production is increased by 
GnRH in isolated granulosa cells of domestic chickens (Hertelendy 
et al., 1982). Differences in the stimulatory/inhibitory properties of 
GnRH in non-mammalian vertebrate gonads appear to be isoform-, 
species- and sex-dependent.
effects of gonadal gnrh on steroId bIosynthesIs In the 
mammalIan testes
GnRH immunoreactivity was first identified in the rat testis in 
1981 (Paull et al., 1981) and rats have since been consistently 
used as a mammalian model for studies on the activity of gonadal 
GnRH-I. The GnRH-I R (GnRH type 1 receptor) in rat gonad is 
structurally identical to that in the pituitary (Moumni et al., 1994). 
Functionally, in immature rat testicular cells, GnRH decreases 
hCG/FSH- stimulated androstanediol and androsterone produc-
tion, but not steroidogenic acute regulatory (StAR) protein and 
progesterone production (Hsueh et al., 1981). The short-term 
(4 h) effect of the GnRH agonist LHRH ethylamide on Leydig 
cells is to stimulate steroidogenesis, but in contrast, 24-h stimu-
lation with the agonist inhibits responsiveness to LH and hCG 
(Sharpe et al., 1982). In another study using adult rat primary 
testis culture, GnRH agonist decreased testosterone (T), andros-
tenedione and 17a-OH progesterone (Hsueh et al., 1983). In yet 
another study, GnRH agonists inhibited LH-dependent steroid 
production in a dose-dependent fashion and abolished the acute 
testosterone rise in response to hCG. The expression of functional 
GnRH receptor during culture and its suppression by LH suggest 
that there is an interaction between pituitary gonadotropins and 
the gonadal GnRH system. It is likely that pituitary gonadotropins 
exert a tonic inhibitory effect upon testicular GnRH receptors. The 
presence of a functional GnRH receptor and inhibitory actions of 
GnRH agonists in cultured fetal and neonatal Leydig cells indi-
cates that GnRH-related peptides can influence the actions of 
gonadotropins on the fetal Leydig cell population (Dufau and 
Knox, 1985).
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gnIh In gonads
Gonadotropin-inhibitory hormone was so named for its discovery 
as an inhibitor of LH release from the pituitary of Japanese quail 
(Tsutsui et al., 2000). Later work has shown that GnIH inhibits 
both LH and FSH synthesis and secretion from the pituitary of 
birds and mammals (Kriegsfeld et al., 2006; Tsutsui et al., 2007). 
GnIH not only acts at the level of the pituitary gland to influence 
gonadotropin synthesis and release, but also within the brain of 
birds and mammals to inhibit GnRH neurons (see Bentley et al., 
2006a, 2009; Tsutsui et al., 2009 for reviews). Therefore, there are 
several lines of evidence that GnIH can act directly on multiple 
components of the HPG axis.
Motivated by the direct action of GnIH on the other tissues of 
the HPG axis, we investigated the possibility that GnIH and/or its 
receptor are present in and act directly on the gonads of vertebrates. 
It is now clear that GnIH and GnIH-R are expressed in the gonads 
of birds and mammals, suggesting that GnIH acts directly elsewhere 
in the reproductive system. Further, our experimental evidence 
from pharmacological manipulations indicates that gonadal GnIH 
is responsive to cues from peripheral hormones and influences 
gonadal steroid release. These findings are important for us to 
understand the endocrine-behavior interactions when consider-
ing an animal’s behavioral ecology. Further, a localized regulatory 
system in reproductive tissues is an important consideration/target 
for reproductive/contraceptive therapies.
conservatIon of gonadal gnIh expressIon and actIons
A role for a local action of GnIH in vertebrate gonads was first 
hypothesized when systemic receptor fluorography revealed bind-
ing sites for GnIH on the thecal and granulosa layers of the ovary 
and within the interstitium and seminiferous tubules of the testes 
of white crowned sparrows (Zonotrichia leucophrys; Wingfield et al., 
2004). Building upon this initial finding, gonadal GnIH was first 
characterized in European starlings and Japanese quail, species of 
two different orders of birds (Bentley et al., 2008). Transcripts for 
GnIH and GnIH-R were found in the quail and starling testes, quail 
epididymis, starling vas deferens and starling ovary and oviduct, indi-
cating its potential as a paracrine/autocrine regulator within repro-
ductive tissues. Immunohistochemistry and in situ hybridization 
further localized production sites of GnIH and GnIH-R to specific 
cell types involved in steroid biosynthesis and gamete maturation in 
the gonads. GnIH-immunoreactivity (GnIH-ir), indicating the pres-
ence of mature peptide, was detected in thecal and granulosa cells of 
starling ovaries and in the interstitium of the testes and psuedostrati-
fied columnar epithelium of the epididymus of quail testes (Bentley 
et al., 2008). In house sparrow testes, GnIH mRNA is present in the 
interstitium (McGuire and Bentley, 2010). GnIH-R mRNA was local-
ized to the germ cells and interstitium of starling and house sparrow 
(Passer domesticus) testes (Bentley et al., 2008; McGuire and Bentley, 
2010). In house sparrows, germ cell expression of GnIH-R was fur-
ther characterized as secondary spermatocyte expression (McGuire 
and Bentley, 2010). In the ovary of chickens (Gallus domesticus), 
GnIH-R mRNA was detected in the thecal and granulosa layers by 
RT-PCR (Maddineni et al., 2008). GnIH mRNA has not been detected 
in chicken ovary (Maddineni et al., 2008), although sequencing of 
PCR products confirms the presence of transcripts for GnIH in the 
GnRH-II R), in the testes and ovary (Bahk et al., 1995; Millar 
et al., 2001; Neill, 2002). Both receptors are members of the seven 
transmembrane family of G protein-coupled receptors and asso-
ciated with Gαq protein. GnRH-II R contains a c-terminal tail 
consistent with receptors able to internalize in response to high 
ligand concentration, while GnRH-I R lacks this tail and does 
not undergo receptor desensitization (Neill, 2002). Although rats 
have been used a pharmacological and medical model, the pres-
ence of cGnRH-II and its receptor have not been identified in 
rat gonads. In fact, the transcripts of cGnRH-II and GnRH-II 
R appear to be truncated in rat cDNA libraries generated from 
other tissues (Stewart et al., 2009). Thus it is hypothesized rats 
do not code for a functional GnRH-II R, and thus receptor den-
sitization is a moot point for them. In human granulosa-luteal 
cells, GnRH-I inhibits progesterone production (as it does in 
rats), and this effect is completely reversed by the MEK1 inhibi-
tor PD98059, indicating GnRH-I acts through the MAP kinase 
signaling pathway (Kang et al., 2000). cGnRH-II also inhibits 
basal and hCG-stimulated progesterone production and LH/FSH 
receptor expression (Kang et al., 2001). GnRH-I agonists have 
also been implicated in causing apoptosis in granulosa-luteal cells 
(Zhao et al., 2000). If gonadal GnRH decreases LH/FSH recep-
tors, inhibits basal and hCG-stimulated progesterone produc-
tion and increases apoptosis in the corpus luteum, it may serve 
a functional role in luteolysis. GnRH-I and cGnRH-II expres-
sion have been mapped across the luteal phase in primates and 
their comparative mRNA levels are consistent with this projec-
tion. GnRH-I mRNA expression is maximal at luteal regression, 
although GnRH-I R mRNA remains low throughout the luteal 
phase (Chakrabarti et al., 2008). An enhanced explanation of 
GnRH actions on the ovary during follicular development can 
be seen in Figure 1.
Less is known about the functional significance of GnRH-I and 
cGnRH-II and their receptors in the human and non-human pri-
mate testes. This is probably due to the greater availability of and 
higher occurrence of treatment on female reproductive tissues in 
fertility treatments. Although the bioactivity of systemically deliv-
ered GnRH antagonists has been studied for 25 years in primates in 
anticipation of their use as a male contraceptive (Weinbauer et al., 
1984) and chemotherapy protectant (cetrorelix, Boekelheide et al., 
2005), the testicular effects of GnRH-I and cGnRH-II are highly 
dependent upon reduced LH and FSH secretion from the pituitary 
and there have been no attempts to quantify direct effects of GnRH 
ex vivo. lGnRH and sGnRH transcripts have not been identified 
in primate gonads.
comparIng the actIons of hypothalamIc and gonadal gnrh: 
What can We Infer?
Gonadal GnRH appears to act non-genomically, modifying enzyme 
activity through inositol phosphate breakdown via stimulation of 
its Gαq receptor (Davis et al., 1986). This is also the mechanism 
used by hypothalamic GnRH on the pituitary for LH/FSH secre-
tion. However differences between gonadotropes and granulosa/
luteal/interstitial cells cause the action of GnRH to be classified as 
“stimulatory” to reproduction in the pituitary and “inhibitory” to 
reproduction in the gonads.
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and its putative rodent receptors, GPR-147 and GPR-74 (Zhao et al., 
2010). The two receptors are differentially present across the sperma-
togenic cycle; GPR 147 is present at all stages, while GPR-74 immuno-
reactivity is observable in late elongated spermatids only, indicating 
their expression may be stage-regulated. The sequential expression of 
RFRP and GPR-74 across different spermatogenic stages would allow 
a role for RFRP in the differentiation of germ cells in the testes.
gonadal gnIh In prImates
The sperm development patterns of rodents and primates are quite 
similar (Clermont, 1972). Thus data garnered from the expres-
sion patterns of RFRP and GPR-74 across the spermatogenesic 
cycle of hamsters provide an excellent model for studies of sperm 
development issues in humans. Although the gonadal expression 
of RFRP and OT7T022, its human cognate receptor, have not been 
studied in humans, RFRP and OT7T022 are expressed in the human 
hypothalamus (Ubuka et al., 2009).
RFRP is not observed in the interstitium of Syrian hamsters. 
However, RFRP-ir and mRNA are present in the steroid biosyn-
thetic cells as well as the germ cells of the rhesus macaque (Macaca 
ovaries of the other bird species studied (McGuire and Bentley, 2010; 
McGuire et al., 2010). It is possible these birds carry an ovarian tran-
script not detectable by our current methods. 
The sites of GnIH-R synthesis across birds are consistent with 
fluorescent GnIH binding observed in the first white crowned 
sparrow study. Thus GnIH-R transcript detection is most likely 
associated with functional receptors and appears conserved across 
passeriform and galliform birds.
Expression of GnIH mRNA and presence of GnIH peptide in 
steroid biosynthetic cells of the ovary and the testes, coupled with 
the presence of its Gαi protein-coupled receptor there, provide the 
potential for this system to act in a paracrine/autocrine fashion to 
regulate steroid biosynthesis. As well, these findings indicate gonadal 
GnIH may be an important target for steroid production therapies. 
Furthermore, the expression of these components on germ cells 
indicates the gonadal GnIH system may be an important considera-
tion in the development of gamete maturation therapies.
The mammalian ortholog of GnIH, RFRP, and its receptor are also 
present in the gonads of mammals. Syrian hamster spermatocytes and 
round to early elongated spermatids are immunoreactive for RFRP 
FIGuRe 1 | Theoretical construct of local gonadotropin-releasing 
hormone (GnRH) action on follicular development in the mammalian 
ovary, based on experimental evidence. GnRH and GnRH receptor 
(GnRH-R) are expressed on granulosa cells at all stages of follicular 
development and on granulosa-luteal cells of corpora lutea. Prehierarchical 
follicles (1) are not stimulated by Follicle stimulating hormone (FSH) and 
gonadal GnRH reduces granulosa cell numbers by reducing proliferation and 
increasing apoptosis in these follicles (Takekida et al., 2003). As follicles gain 
the ability to respond to FSH, they overcome this inhibition and grow into 
small/medium hierarchical follicles (2). GnRH increases apoptosis of granulosa 
cells in these follicles, but this does not cause a significant reduction in the 
secretion of already low levels of estradiol (E2) and progesterone (P) (Takekida 
et al., 2003). FSH, P and E2 enhance the growth of these follicles into large 
hierarchical follicles (3). GnRH reduces granulosa cell proliferation, aromatase 
activity (Gore-Langton et al., 1981) and luteinizing hormone receptor (LH-R) 
expression (Hsueh et al., 1980) while continuing to increase granulosa cell 
apoptosis (Takekida et al., 2003). All of these factors contribute to a significant 
decrease in the secretion of E2 and P from these follicles (Hsueh et al., 1980; 
Takekida et al., 2003). The reduction in LH-R also makes the follicle less able to 
respond to the LH surge with ovulation. If large hierarchical follicles are not 
able to overcome this inhibition, their growth will cease and they would 
become atretic (4). If a large hierarchical follicle does overcome inhibition by 
GnRH it can become the corpus luteum (5) post-ovulation. GnRH decreases 
LH-R and FSH-R expression in, reduces secretion of progesterone from and 
increases apoptosis of granulosa-luteal cells (Kang et al., 2000, 2001; Zhao 
et al., 2000). The highest expression of GnRH and GnRH-R occurs at the end 
of the luteal phase (Chakrabarti et al., 2008), indicating GnRH may be a 
contributing factor to luteolysis. The diagram on the right is a representation of 
the photomicrograph on left, showing the relative location of each follicular 
stage for clarity.
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a regulatory role. It is not at present clear why hamsters differ from 
songbirds and rhesus macaques in the expression patterns of GnIH 
and its receptor.
Although human reproductive cycles are not thought to be regu-
lated by photoperiod or rain, they nonetheless retain the ability to 
modulate their reproductive output during times of food restriction 
and stress (Vigersky et al., 1977; Vermeulen, 1993; Ferin, 1999). The 
conserved nature of gonadal neuropeptide systems makes it likely 
that this mechanism allowing for enhanced reproductive respon-
siveness is most likely conserved in humans as well. 
comparIng the actIons of hypothalamIc and gonadal gnIh: 
What can We Infer?
Although the expression sites/pattern of GnIH and its receptor are 
suggestive of a role in steroid synthesis and gamete maturation, a 
general inhibitory action for the peptide cannot be inferred simply 
based on direct inhibition of GnRH (Ducret et al., 2009) and LH/
FSH (Tsutsui et al., 2000) by its more characterized counterpart 
in the hypothalamus. However, GnIH-R has the same sequence, is 
recognized by the same antibodies and mRNA probes and binds flu-
orescently-labeled GnIH identically to pituitary GnIH-R (Wingfield 
et al., 2004; Bentley et al., 2008; Maddineni et al., 2008; McGuire 
mulatta) testes. mRNA for OT7T022, the putative macaque RFRP 
receptor, is also expressed there (Figure 2). In situ hybridization 
reveals the presence of transcripts for RFRP in Leydig cells, sper-
matogonia, and spermatocytes. The location of OT7T022 mRNA 
on spermatogonia, spermatocytes and Sertoli cells and Leydig 
cells (Figure 3). RFRP and OT7T022 are also expressed on rhesus 
macaque ovarian tissue. RFRP-ir and mRNA and OT7T022 mRNA 
are present on granulosa cells and oocytes of preantral follicles 
(Figure 2). Non-hierarchical follicles and corpora lutea were not 
tested. Cell types were identified based on rhesus macaque gonadal 
morphology (Gougeon, 1996; Boekelheide et al., 2005), and with 
concurrent sections labeled with hematoxylin and eosin stain (data 
not shown). RFRP thus has the potential to act as a regulator of 
steroid biosynthetic cells and gametes in rhesus macaque testes 
and ovaries.
The expression pattern of RFRP and OT7T022 in primate gonads 
appears to be more closely related to that observed in seasonally-
 breeding songbirds than to hamsters (Table 2). Like house sparrows 
and hamsters, rhesus macaques undergo seasonal cycles of gonadal 
growth and regression characterized by significant changes in sex 
steroids and gametogenesis (Riesen et al., 1971; Gupta et al., 2000; 
Bansode et al., 2003), in which the gonadal GnIH system may play 
FIGuRe 2 | In situ hybridization for RF-amide related peptide (RFRP) 
and its receptor (OT7T022) in rhesus macaque (Macaca mulatta) 
ovary. RFRP antisense probe labels mRNA in granulosa cells and oocytes 
(A). An adjacent section incubated with RFRP sense probe (control) is 
shown in (B). OT7T022 antisense probe labels mRNA in granulosa cells 
and oocytes (C). An adjacent section incubated with OT7T022 sense 
probe (control) is shown in (D). Black arrows, granulosa cells. Striped 
arrowheads, oocytes.
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Table 2 | Summary of RFRP and OT7T022 mRNA and peptide localization in rhesus macaques.
Cell type Macaque RFRP Macaque OT7T022 Avian GnIH Avian GnIH-R Rodent RFRP Rodent GPR74
Spermatogonia      
Spermatocytes      
Spermatids - - - -  
Spermatozoa - - - -  
Sertoli cells -  - - - -
Leydig cells      
Seminiferous tubules      
Interstitium     - -
Oocytes   - -  
Granulosa cells      
Thecal cells - -    
Avian GnIH mRNA and peptide and GnIH-R mRNA and binding sites characterized in European starlings (Sturnus vulgaris, Bentley et al., 2008), house sparrows 
(Passer domesticus, McGuire and Bentley, 2010), Japanese quail (Coturnix japonica, Bentley et al., 2008) and domestic chicken (Gallus gallus, Maddineni et al., 2008). 
Rodent RFRP and GPR74 peptides characterized in hamster (Mesocricetus auratus, Zhao et al., 2010). Checkmarks indicate presence in the cell type, dashes denote 
lack of mRNA, peptide or binding sites and blank spaces indicate lack of evidence.
et al., 2010). Yin et al. (2005) identified GnIH-R in quail pituitary as a 
member of the GPCR family coupled to Gαi/o. Thus agonist binding 
of this receptor causes inhibition of adenylate cyclase. Hinuma et al. 
(2000) showed that agonist binding of rat RFRP receptor reduced the 
forskolin-induced cAMP response in transfected Chinese hamster 
ovary (CHO) cells. Inhibition of forskolin- stimulated adenylate 
cyclase and consequent decreased cAMP accumulation was later 
confirmed in chicken pituitary (Shimizu and Bédécarrats, 2010). 
Thus it is likely that binding of GnIH/RFRP to it receptor in the 
gonads also reduces cAMP accumulation and inhibits transcription 
of proteins with cAMP responsive elements.
gonadal gnIh and testosterone synthesIs
GnIH has the potential to, but does it actually directly affect testoster-
one synthesis in the testes? Systemic (intraperitoneal) administration 
of GnIH to male quail reduced plasma testosterone and caused apop-
FIGuRe 3 | In situ hybridization for RF-amide related peptide (RFRP) and 
its receptor (OT7T022) in rhesus macaque (Macaca mulatta) testis. RFRP 
antisense probe labels mRNA in Leydig cells, spermatogonia and 
spermatocytes (A). An adjacent section incubated with RFRP sense probe 
(control) is shown in (B). OT7T022 antisense probe labels mRNA in Leydig 
cells, Sertoli cells, spermatogonia and spermatocytes (C). An adjacent 
section incubated with OT7T022 sense probe (control) is shown in (D). White 
arrows, Leydig cells. Gray arrows, spermatogonia. Black arrows, 
spermatocytes. Black arrowheads, Sertoli cells. All figures to scale, scale 
bar = 50 µm.
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ovaries (Maddineni et al., 2008). Among mature hens, GnIH-R 
mRNA is significantly decreased by estradiol and progesterone alone 
and in combination (Maddineni et al., 2008). Like the differential 
expression of RFRP and GPR-74 in Syrian hamster testes, ovarian 
GnIH-R/OT7T022 has hierarchical expression in the ovary. GnIH-R 
mRNA is expressed on both prehierarchical and preovulatory fol-
licles in hens (Maddineni et al., 2008) and on preantral follicles in 
macaque (Figure 2). There is no difference in the relative levels of 
GnIH-R mRNA on granulosa cells between the two stages of hen 
follicles, although prehierarchical follicles express significantly more 
GnIH-R mRNA on their thecal cells than do preovulatory follicles. 
We therefore propose this scenario: in the absence of FSH stimula-
tion, GnIH reduces granulosa cell viability in follicles (which would 
all be prehierarchical in the absence of FSH), reducing estradiol secre-
tion and inhibiting their maturation. As follicles mature, expression 
of GnIH-R mRNA on the theca is reduced, allowing them to respond 
to an LH surge with ovulation and progesterone production. Post-
ovulation, granulosa cell numbers of hierarchical follicles that did not 
ovulate are reduced in the absence of FSH and presence of unchanged 
levels of GnIH-R, causing follicular atresia. Overall, evidence suggests 
ovarian GnIH has the greatest regulatory capability in prepubertal 
hens and in the prehierarchical or atretic follicles of sexually mature 
hens, in contrast to the effects seen in males.
The mechanism and timing of regulation by gonadal GnIH may 
be very different in male and female gonads. In males, GnIH acts 
as a regulator of stimulated testosterone production and possibly 
gamete maturation. In females, GnIH has a role in the prevention 
of follicle maturation and ovulation. As with gonadal GnRH, there 
appear to be sex differences in the actions of gonadal GnIH.
gonadal gnIh and the organIsm’s envIronment
Is the gonadal GnIH system able to directly respond to environ-
mental cues? New evidence from starling testes and ovaries indi-
cates that LH/FSH-stimulated testosterone and estradiol levels are 
directly reduced by cortisol and melatonin (McGuire et al., 2010, 
unpublished observation). Cultures treated with cortisol and mela-
tonin also show higher levels of GnIH mRNA relative to LH/FSH-
stimulated cells (McGuire et al., 2010, unpublished observation). 
Thus it is likely that the gonads directly respond to stress and an 
endocrine proxy of day length. Although changes in seasonal day 
length are not cause for concern in most humans, these results point 
toward significant effects in shift workers, pilots/flight attendants 
and those who self-medicate with over-the-counter melatonin. 
The stress-related hormone cortisol may act on GnIH and other 
factors to reduce follicle maturation. This might have evolved as 
an adaptive process, allowing an organism to wait to breed until 
conditions are more favorable – but it may be one mechanism in 
stress-induced infertility. Additionally, corticosteroid pharmaceuti-
cals may have biologically significant effects on estradiol production 
and ovarian function. Recently, we found that female rats express 
glucocorticoid receptor (GR) transcripts in their ovaries, even when 
not stressed (McGuire et al., unpublished observation). However, 
they still significantly increase GR mRNA in the ovary in response 
to chronic, but not acute stress. This indicates that the ovaries are 
highly responsive to levels of the stress hormone cortisol in the 
plasma and that they may become increasingly responsive to stress-
ful events with repeated exposure.
tosis in testicular germ cells (Ubuka et al., 2006). These researchers 
concluded that the effects were caused by a reduction in LH secretion 
from the pituitary. However, the administration route for GnIH (i.p. 
via osmotic pumps) did not prevent its action elsewhere in the HPG 
axis. GnIH could be acting both to decrease LH secretion from the 
pituitary (indirectly effecting testosterone secretion) and by bind-
ing its receptor in the gonads and directly decreasing testosterone. 
The presence of GnIH receptor was later identified in quail testes 
(Bentley et al., 2008), specifically on germ cells and in the interstitium. 
A  parsimonious explanation of these data is that significant apoptosis 
in germ cells of GnIH-treated birds versus saline control birds resulted 
from lack of testosterone support (testosterone reduced by lower LH 
stimulation and higher direct GnIH inhibition) and/or direct action 
of GnIH on germ cells. Additionally, the observed reduction in tes-
tosterone was the result of both reduced gonadotropin support and 
direct action of GnIH in the interstitium. New evidence from house 
sparrows suggests that GnIH can directly reduce testosterone secre-
tion from the testes. 1 and 10 uM doses of GnIH significantly reduced 
the amount of testosterone secreted from LH/FSH- stimulated house 
sparrow testes cultured in vitro (McGuire and Bentley, 2010). GnIH 
does not have a significant effect on basal testosterone synthesis, sug-
gesting the gonadal GnIH system acts to regulate high levels of testo-
sterone secretion and would have the greatest regulatory capability 
in post-pubertal males. Thus GnIH can reduce testosterone via two 
mechanisms: GnIH reduces LH/FSH secretion from the pituitary, 
decreasing stimulation to produce testosterone and GnIH inhibits 
testosterone secretion in the testes directly, in the presence of LH/
FSH stimulation.
Why would such a system be necessary? Why not constantly 
support tonically high levels of testosterone, the highest sperm pro-
duction levels and the highest frequency of reproductive displays 
possible? High testosterone levels are associated with a number of 
pathologies in vertebrates, including prostate cancer and immu-
nocompromise (Gann et al., 1996; Roberts et al., 2007). The brain 
already controls a mechanism whereby high levels of gonadal ster-
oids limit further secretion of the hormones that stimulate their 
synthesis, but this process requires a lengthy and time-consuming 
feedback loop. Fine-tuning of testosterone secretion on-site is 
highly adaptive in species with temporally or socially constrained 
breeding - especially if that system (in this case the gonad) is able 
to respond directly to environmental cues.
gonadal gnIh and estradIol synthesIs
Based on its distribution, GnIH has the potential to, but does it 
actually directly affect estradiol synthesis in the ovary? The viability 
of granulosa cells from chicken ovaries was significantly reduced 
when cultured with GnIH alone but not when FSH was present in 
the culture medium (Maddineni et al., 2008). Dispersion culture 
of whole European starling ovary reveals that GnIH reduces basal, 
but not LH/FSH-stimulated estradiol production (McGuire et al., 
2010). Taken together, these data suggest that GnIH affects basal 
estradiol synthesis in the ovary by reducing viability of granulosa 
cells and this effect is rescued by FSH.
The expression pattern of GnIH-R in ovaries is consistent with the 
observed reduction of basal, but not gonadotropin-stimulated estra-
diol production. Sexually immature chickens express significantly 
more ovarian GnIH-R mRNA compared to sexually mature chicken 
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concludIng remarks
It is clear from the differences in action of GnRH, and sites of syn-
thesis and receptor binding of GnIH in different study organisms 
even within the same vertebrate class that it would be unwise to cre-
ate any sweeping generalizations about the gonadal actions of these 
peptides. The take-home message is that despite our knowledge of 
the existence of many gonadal neuroeptide systems (see Table 1) 
we still only have a vague understanding of how they operate and 
are regulated. It is also clear that we cannot assume that a gonadal 
neuropeptide will operate in a similar manner to its hypothalamic 
counterpart. Given that GnRH is the most well-studied gonadal 
neuropeptide our knowledge of it is rather poor. However, study of 
gonadal GnRH has provided us with some ideas as to how the HPG 
axis might have evolved from a common ancestor, and some impor-
tant insights as to its gonadal actions. Table 1 indicates the large 
gaps in our knowledge of the existence of gonadal neuropeptides 
in different vertebrate classes; further comparative studies can only 
be beneficial in terms of creating a framework of knowledge upon 
which we can build and create novel therapeutic drugs, deepen our 
understanding of the evolution of the vertebrate reproductive sys-
tem, and provide us with clues as to how the gonadal neuropeptides 
have adapted to the ecology of different vertebrates. In part, the 
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Further, the functional names given to the gonadal counterparts 
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the gonads in terms of discovering new gonadal neuropeptides 
in different vertebrate classes as well as elucidating the actions of 
those already known to exist.
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current pharmacology of gonadal gnrh and gnIh
Why do transient increases in GnIH or GnRH and decreases in 
testosterone and estradiol matter? Repeated events which stimulate 
or inhibit this system over time may lead to decreased fertility or 
increased cancer risk. Can pharmacological treatments manipu-
late this ratio favorably? Will pharmacological treatments inadvert-
ently manipulate this ratio unfavorably? Should gonadal GnIH and 
GnRH be considered in the development of new contraceptives/
fertility treatments/cancer therapies?
gnrh and ovarIan cancer lInes
The stimulatory potential of GnRH-I has already made it a target of 
oncology. For example, GnRH antagonists and cytotoxic GnRH ana-
logues have been used to inhibit the pituitary and retard growth of 
ovarian and prostate cancers (Schally, 1999). However, the assumed 
function of these systemic treatments precludes the ability of GnRH 
to act directly on the ovary. In the case of GnRH antagonists, the 
therapy may in fact further proliferation within the gonad and 
reduce programmed cell death. The direct inhibitory capability of 
GnRH analogs on granulosa cells of the ovaries of a variety of species 
indicates that there is the potential for some therapies to be more 
localized: direct application of GnRH agonists or cytotoxic GnRH at 
the gonadal tumor site to reduce proliferation and cause apoptosis 
locally, while sparing the rest of the ovary. Further research is needed 
to determine GnRH receptor expression in cancerous cells. GnRH-II 
has been less well studied than GnRH-I.. However, GnRH-II and 
its receptor are expressed in human ovarian cancer cell lines and 
native GnRH-II dose- and time-dependently reduces proliferation 
in those cancer cells (Gründker et al., 2002). The observed effect 
is significantly more potent than the anti-proliferative ability of 
GnRH-I. As well, these researchers showed GnRH-II was able to 
reduce proliferation in another ovarian cancer cell line, SK-OV-3, 
which is not responsive to GnRH-I. Development of GnRH-II ana-
logues will further this line of research.
gnIh antagonIst
RF9 is a recently reported agent that blocks opiod-induced hyperal-
gesia by antagonizing the NPFF receptor. RF9 also antagonizes the 
closely related RFRP receptor, preventing regulation of the HPG 
axis by RFRP. A pharmacological dose of RF9, delivered in a single 
bolus ICV injection, causes robust secretion of LH and FSH in 
diestrus-1 and estrus female rats (Pineda et al., 2010). These profiles 
are stronger and longer lasting than those induced by kisspeptin 
administered ICV. In male rats, RF9 causes a robust, but transient 
increase in LH secretion. Thus, pharmacological doses of this 
chronic pain treatment antagonize RFRP receptor and remove its 
inhibitory action from LH/FSH secretion. The researchers point 
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